ruo ghk-cu Research Peptide 50 mg GHK-CU 50mg (10 Vials) -

NKTCL cell lines treated with ARQ197, an ATP-non-competitive selective c-MET inhibitor which is currently in phase 3 clinical trials in NSCLC patients, reduced the proliferative response by approximately 50% in two of three cell lines, indicating that the HGF/c-MET signaling is partly responsible for NKTCL proliferation [49]

10.1016/j.vaccine.2014.06.054 Vaccine 228 UntiM.JaffreyS

But if youre taking copper and vitamin C, the combination can be dangerous

Nucleosides Nucleotides Nucleic Acids 40:505517

It helps produce myelin, the protective covering around nerves, which allows efficient communication between the brain and body